Oncology research has never been more important than it is today, and IDT’s xGEN™ NGS tools are uniquely positioned to take your research further.
IDT is a sponsor and exhibitor at the 55th annual European Human Genetics (ESHG) conference in Vienna and we are ready to demonstrate how we can help transform limitations into opportunities.
Come to network, attend our seminars, or just chat – we look forward to seeing you.
Yesterday’s limitations are tomorrow’s opportunities – especially when it comes to oncology research.
In this seminar, we will explore some of IDT’s newest NGS technologies that enable researchers to discover and detect with high confidence targetable biomarkers using NGS. Molecular characterization of tumor types for research is now possible even with low-quality or low-quantity challenging samples.
In the second part, we will hear how NGS is advancing hematology research from one of the world’s largest leukemia labs.
Contribute to knowledgebases, find signatures, and reveal elusive new cancer mutations with NGS solutions from IDT.
xGen NGS – enabling new discoveries in NGS research
Jordan Young, Market Development Manager, Integrated DNA Technologies
The future of personalized genomics: Advancing hematology research with NGS
Manja Meggendorfer, Head of Molecular Genetics, MLL Munich Leukemia Laboratory